Cargando…
Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals
Oncolytic peptides and peptidomimetics are being optimized for the treatment of cancer by selecting agents with high cytotoxic potential to kill a maximum of tumor cells as well as the capacity to trigger anticancer immune responses and hence to achieve long-term effects beyond therapeutic discontin...
Autores principales: | Zhou, Heng, Mondragón, Laura, Xie, Wei, Mauseth, Brynjar, Leduc, Marion, Sauvat, Allan, Gomes-da-Silva, Lígia C., Forveille, Sabrina, Iribarren, Kristina, Souquere, Sylvie, Bezu, Lucillia, Liu, Peng, Zhao, Liwei, Zitvogel, Laurence, Sveinbjørnsson, Baldur, Eksteen, J. Johannes, Rekdal, Øystein, Kepp, Oliver, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199251/ https://www.ncbi.nlm.nih.gov/pubmed/30352991 http://dx.doi.org/10.1038/s41419-018-1127-3 |
Ejemplares similares
-
Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer
por: Fleten, Karianne Giller, et al.
Publicado: (2021) -
Toxicity of Dithiothreitol (DTT) to Drosophila melanogaster
por: Wang, Yiwen, et al.
Publicado: (2020) -
Parent Implementation of DTT Following Telehealth Instruction
por: Gauert, Spencer, et al.
Publicado: (2022) -
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma
por: Eike, Liv-Marie, et al.
Publicado: (2016) -
Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors
por: Rekdal, Öystein, et al.
Publicado: (2015)